What is he best known for?
The fields of study he is best known for:
Mirco Ponzoni mainly investigates Neuroblastoma, Cancer research, Pathology, Cell culture and Apoptosis.
His Neuroblastoma research includes themes of Angiogenesis, Liposome, Chemotherapy, Doxorubicin and In vivo.
The Cancer research study combines topics in areas such as Cytotoxic T cell and Cell growth.
Mirco Ponzoni combines subjects such as Endocrinology, Internal medicine and Propidium iodide with his study of Cell growth.
His research in Pathology intersects with topics in Macrophage and Neovascularization.
His research integrates issues of Methylation, Gene, DNA methylation, Molecular biology and Promoter in his study of Cell culture.
His most cited work include:
- Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy (265 citations)
- Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. (218 citations)
- Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. (207 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Neuroblastoma, Cancer research, Cell culture, In vivo and Molecular biology.
His Neuroblastoma research integrates issues from In vitro, Liposome, Doxorubicin, Pathology and Pharmacology.
His work carried out in the field of Cancer research brings together such families of science as Immunology, Apoptosis, Cell growth and Fenretinide.
His Cell culture study combines topics from a wide range of disciplines, such as Endocrinology, Cellular differentiation, Biochemistry, Internal medicine and Cell biology.
In his research on the topic of In vivo, Targeted therapy is strongly related with Nanocarriers.
His Molecular biology research incorporates themes from Gene expression, Gene and Oncogene.
He most often published in these fields:
- Neuroblastoma (56.93%)
- Cancer research (51.49%)
- Cell culture (23.27%)
What were the highlights of his more recent work (between 2016-2021)?
- Neuroblastoma (56.93%)
- Cancer research (51.49%)
- In vitro (16.34%)
In recent papers he was focusing on the following fields of study:
Mirco Ponzoni focuses on Neuroblastoma, Cancer research, In vitro, In vivo and Nanocarriers.
His Neuroblastoma research is classified as research in Cell culture.
His study of Angiogenesis is a part of Cancer research.
His study looks at the relationship between In vitro and fields such as Doxorubicin, as well as how they intersect with chemical problems.
Mirco Ponzoni works mostly in the field of In vivo, limiting it down to topics relating to Cytotoxicity and, in certain cases, Toxicity, Biophysics, Autophagy, Tyrosine kinase and Viability assay, as a part of the same area of interest.
His Nanocarriers research is multidisciplinary, relying on both Receptor, Integrin, Biochemistry, Cell biology and Deamidation.
Between 2016 and 2021, his most popular works were:
- Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer. (52 citations)
- A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A (44 citations)
- Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation. (32 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Cancer research, Neuroblastoma, Immunology, Cancer and Cancer cell.
His study in Cancer research is interdisciplinary in nature, drawing from both Targeted therapy, Targeted drug delivery, Nanocarriers, Drug and Pediatric cancer.
In his works, Mirco Ponzoni undertakes multidisciplinary study on Neuroblastoma and Isotretinoin.
His work deals with themes such as Clodronic acid and Phenotype, which intersect with Immunology.
His work carried out in the field of Cancer brings together such families of science as Adipose tissue, Antibody, Mesenchymal stem cell and Bone marrow.
His work in Cancer cell addresses subjects such as Mutant, which are connected to disciplines such as In vitro.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
